Centessa Pharmaceuticals (LTS:0ACX) Marketable Securities : $98.96 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Centessa Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Centessa Pharmaceuticals's Marketable Securities for the quarter that ended in Dec. 2024 was $98.96 Mil.

Centessa Pharmaceuticals's annual Marketable Securities increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($128.52 Mil) but then declined from Dec. 2023 ($128.52 Mil) to Dec. 2024 ($98.96 Mil).

Centessa Pharmaceuticals Marketable Securities Historical Data

The historical data trend for Centessa Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centessa Pharmaceuticals Marketable Securities Chart

Centessa Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

128.52

98.96

Centessa Pharmaceuticals Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial												128.52	111.96	167.46	123.42	98.96

Centessa Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Centessa Pharmaceuticals (LTS:0ACX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Centessa Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of Centessa Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Centessa Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Centessa Pharmaceuticals PLC (LTS:0ACX) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

CNTA:USA

Address

1 Ashley Road, 3rd Floor, Altrincham, Cheshire, GBR, WA14 2DT

Website

https://www.centessa.com

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Centessa Pharmaceuticals Headlines

No Headlines